Couling John D's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed May 6, 2026
- Accession no.
- 0001193125-26-209338
- Filed
- May 6, 2026
- Trade date
- May 4-5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $715.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Couling John DCIK 0001894052 | Officer (SVP, Entertainment) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Class A Common Stock | SSaleDisposed | −4,688 | $58.47 | −$274,107.36 | 118,353 | Direct | |
| May 5, 2026 | Class A Common Stock | MOption exerciseAcquired | +7,666 | $45.50 | +$348,803 | 126,019 | Direct | |
| May 5, 2026 | Class A Common Stock | SSaleDisposed | −6,928 | $57.47F2 | −$398,152.16 | 119,091 | Direct | |
| May 5, 2026 | Class A Common Stock | SSaleDisposed | −738 | $58.34F3 | −$43,054.92 | 118,353 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Class A Common Stock | MOption exerciseDisposed | −7,666 | $0.00 | $0 | 38,334 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple transactions at prices ranging from $57.16 to $58.05 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026.
Referenced by the price of 1 transaction in Table I.
- F3
The shares were sold in multiple transactions at prices ranging from $58.195 to $58.36, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026.
Referenced by the price of 1 transaction in Table I.